SM
GILD icon

Stratton Management’s Gilead Sciences GILD Stock Holding History

Stratton Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$3.48M Sell
34,365
-6,070
-15% -$632K 0.42% 94
2015
Q3 		$3.97M Buy
40,435
+11,145
+38% +$1.24M 0.45% 88
2015
Q2 		$3.43M Sell
29,290
-10,005
-25% -$1.09M 0.15% 169
2015
Q1 		$3.86M Buy
39,295
+11,915
+44% +$1.21M 0.16% 164
2014
Q4 		$2.58M Buy
+27,380
New +$2.83M 0.11% 185

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stratton Management's GILD Position: Q4 2015 in Review

Stratton Management reduced its Gilead Sciences (GILD) stake by 15% in Q4 2015, selling an estimated $632K and leaving 34,365 shares worth $3.48M. The position accounts for 0.42% of the portfolio, ranked #94.

Stratton Management first reported a position in GILD in Q4 2014 and has held it in 5 quarters since. The position peaked at $3.97M in Q3 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q4 2015.

  • Stratton Management held 34,365 shares of Gilead Sciences worth $3.48M as of Q4 2015.
  • Stratton Management sold 6,070 Gilead Sciences shares in Q4 2015, an estimated $632K.
  • Gilead Sciences made up 0.42% of Stratton Management's portfolio in Q4 2015, its #94 holding.
  • Stratton Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 5 quarters since.
  • Stratton Management's Gilead Sciences position peaked at $3.97M in Q3 2015.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2015.

Based on Stratton Management's 13F filing for Q4 2015, filed 11 Feb 2016.